☆ 4.6 Editorial Material

Ga-68-Prostate-Specific Membrane Antigen PET/CT in Imaging of Hemangiopericytoma

CLINICAL NUCLEAR MEDICINE (2023)

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-Prostate-Specific Membrane Antigen PET/CT in Ovarian Tumors Potential to Differentiate Benign and Malignant Tumors Before Surgery: A Preliminary Report

Jolanta Kunikowska et al.

Summary: The aim of this study was to evaluate the feasibility of using Ga-68-PSMA-11 PET/CT in detecting ovarian neoplasms before surgical treatment. The results suggest that Ga-68-PSMA-11 PET/CT has the potential to differentiate malignant and benign tumors before surgery.

CLINICAL NUCLEAR MEDICINE (2023)

Add to Collection
Review Medicine, General & Internal

Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis

Barbara Muoio et al.

Summary: The diagnostic accuracy of PET/CT or PET/MRI with PSMA-targeting radiopharmaceuticals in high-grade gliomas (HGG) is high, with a sensitivity of 98.2% and specificity of 91.2%. However, more studies are needed to confirm its promising role in this clinical setting.

DIAGNOSTICS (2022)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

[68Ga]Ga-Prostate-Specific Membrane Antigen PET/CT: a novel method for imaging patients with hepatocellular carcinoma

Jolanta Kunikowska et al.

Summary: The study found that [Ga-68]Ga-PSMA-11 PET/CT imaging can effectively detect PSMA expression in patients with HCC and guide treatment strategies. PET/CT results changed the treatment strategy in 33% of the patients, showing visible heterogeneity of PSMA staining in HCC.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection
Editorial Material Radiology, Nuclear Medicine & Medical Imaging

68Ga-Prostate-Specific Membrane Antigen PET/CT in Sinonasal Glomangiopericytoma-Exploring Theranostic Avenues!

Pirabu Sakthivel et al.

CLINICAL NUCLEAR MEDICINE (2021)

Add to Collection
Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Hemangioblastoma An Unsuspected Pitfall in PSMA PET/CT

Nicolas Gohimont et al.

Summary: Hemangioblastoma is the most common primary intra-axial posterior fossa tumor in adults, and in this case, the intense overexpression of PSMA in tumor-associated vascular structures may explain the abnormal findings in PSMA PET/CT.

CLINICAL NUCLEAR MEDICINE (2021)

Add to Collection
Review Radiology, Nuclear Medicine & Medical Imaging

PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports

M. J. M. Uijen et al.

Summary: PSMA-RLT shows promising results in prostate cancer and may have potential applications in other solid tumors. PSMA is expressed in varying degrees in other malignancies, suggesting a broader clinical implementation of PSMA-RLT beyond prostate cancer.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-Prostate-Specific Membrane Antigen-11 PET/CT A New Imaging Option for Recurrent Glioblastoma Multiforme?

Jolanta Kunikowska et al.

CLINICAL NUCLEAR MEDICINE (2020)

Add to Collection
Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Tumor uptake in glioblastoma multiforme after IV injection of [177Lu]Lu-PSMA-617

Jolanta Kunikowska et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.